GGrantIndex
← Leaderboards

James Joseph Lee

Mayo Clinic Coll Of Med, Mayo Clinic Az

$11,445,121
Attributed
$13,774,236
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY200516
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$13,774,236 · 7

By mechanism

R01$12,632,888 · 4
K26$578,269 · 1
R21$391,738 · 1
R03$171,341 · 1

Top collaborators

Others in their field

Top investigators on “Eosinophil

Research focus

EosinophilLeukocytesInflammationMediatingMouse ModelAllergensAsthmaAllergicResponseProteinsT-LymphocyteLungLung DiseasesInflammatoryBaseDiphtheria ToxinReagentCellsAntibodiesCytoplasmic GranulesEventImmune ResponseGrowthInflammatory Response

Grant awards (38)

Airway Sensory Nerves in Asthma$776,955
R01 · FY2016 · HL
Eosinophil Activities in Murine Models of Lung Disease$415,000
R01 · FY2016 · HL · contact PI
Airway Sensory Nerves in Asthma$765,299
R01 · FY2015 · HL
Eosinophil-nerve Interactions in Mouse Models of Dermatitis$587,665
R01 · FY2015 · AR · contact PI
Eosinophil Activities in Murine Models of Lung Disease$408,775
R01 · FY2015 · HL · contact PI
Airway Sensory Nerves in Asthma$790,455
R01 · FY2014 · HL
Eosinophil-nerve Interactions in Mouse Models of Dermatitis$575,911
R01 · FY2014 · AR · contact PI
Eosinophil Activities in Murine Models of Lung Disease$415,000
R01 · FY2014 · HL · contact PI
Efficacy of BCG Therapy is a Function of Bladder Tumor Immune Microenvironment$175,108
R21 · FY2014 · CA · contact PI
Eosinophil-nerve Interactions in Mouse Models of Dermatitis$558,283
R01 · FY2013 · AR · contact PI
Eosinophil Activities in Murine Models of Lung Diesease$376,992
R01 · FY2013 · HL · contact PI
Efficacy of BCG Therapy is a Function of Bladder Tumor Immune Microenvironment$216,630
R21 · FY2013 · CA · contact PI
Eosinophil-nerve Interactions in Mouse Models of Dermatitis$603,663
R01 · FY2012 · AR · contact PI
Eosinophil Activities in Murine Models of Lung Diesease$396,000
R01 · FY2012 · HL · contact PI
Eosinophil Activities in Murine Models of Lung Diesease$400,000
R01 · FY2011 · HL · contact PI
Eosinophil Activities in Murine Models of Lung Diesease$400,000
R01 · FY2010 · HL · contact PI
Asthma is a Prognostic Indicator for Pulmonary Metastasis of Breast Cancer$78,163
R03 · FY2010 · CA · contact PI
Eosinophil Activities in Murine Models of Lung Diesease$400,000
R01 · FY2009 · HL · contact PI
Eosinophil Recruitment and Activation in Solid Tumors$294,008
R01 · FY2009 · CA · contact PI
Eosinophil Recruitment and Activation in Solid Tumors$152,000
R01 · FY2009 · CA · contact PI
Mechanisms of Eosinophil Effector Functions in the Lung$120,971
K26 · FY2009 · RR · contact PI
Asthma is a Prognostic Indicator for Pulmonary Metastasis of Breast Cancer$93,178
R03 · FY2009 · CA · contact PI
Eosinophil Recruitment and Activation in Solid Tumors$294,008
R01 · FY2008 · CA · contact PI
Mechanisms of Eosinophil Effector Functions in the Lung$118,234
K26 · FY2008 · RR · contact PI
Eosinophil Activities in Murine Models of Lung Disease$365,049
R01 · FY2007 · HL · contact PI
Eosinophil Recruitment and Activation in Solid Tumors$294,008
R01 · FY2007 · CA · contact PI
Mechanisms of Eosinophil Effector Functions in the Lung$115,576
K26 · FY2007 · RR · contact PI
Eosinophil Activities in Murine Models of Lung Disease$375,953
R01 · FY2006 · HL · contact PI
Eosinophil Recruitment and Activation in Solid Tumors$302,789
R01 · FY2006 · CA · contact PI
Mechanisms of Eosinophil Effector Functions in the Lung$112,996
K26 · FY2006 · RR · contact PI
Eosinophil Activities in Murine Models of Lung Disease$385,000
R01 · FY2005 · HL
Eosinophil Recruitment and Activation in Solid Tumors$310,075
R01 · FY2005 · CA
Mechanisms of Eosinophil Effector Functions in the Lung$110,492
K26 · FY2005 · RR
Eosinophil Activities in Murine Models of Lung Disease$385,000
R01 · FY2004 · HL
EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASE$382,500
R01 · FY2003 · HL
EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASE$382,500
R01 · FY2002 · HL
EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASE$382,500
R01 · FY2001 · HL
EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASE$457,500
R01 · FY2000 · HL